Is Unihealth Hosp overvalued or undervalued?
As of August 26, 2025, Unihealth Hosp is fairly valued with a PE ratio of 16.38, an EV to EBITDA ratio of 12.69, and a ROCE of 22.22%, outperforming the Sensex with a year-to-date return of 9.52%, while its valuation is lower than peers like Max Healthcare and Apollo Hospitals.
As of 26 August 2025, the valuation grade for Unihealth Hosp has moved from very attractive to fair. The company appears to be fairly valued at this time. Key ratios include a PE ratio of 16.38, an EV to EBITDA ratio of 12.69, and a ROCE of 22.22%. In comparison to its peers, Unihealth Hosp's PE ratio is significantly lower than that of Max Healthcare, which is very expensive at 95.68, and Apollo Hospitals, which is attractive at 70.89. Despite a recent decline in stock price, Unihealth Hosp has outperformed the Sensex with a year-to-date return of 9.52% compared to the Sensex's 4.51%. Overall, the company is positioned in a competitive landscape but is currently fairly valued based on its financial metrics.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
